INZIMYA Trademark

Trademark Overview

On Tuesday, March 24, 2015, a trademark application was filed for INZIMYA with the United States Patent and Trademark Office. The USPTO has given the INZIMYA trademark a serial number of 79167602. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, August 5, 2022. This trademark is owned by APEIRON BIOLOGICS AG. The INZIMYA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and veterinary preparations for the treatment of cancer; diagnostic preparations for medical purposes; sanitary preparations for medical purposes
inzimya

General Information

Serial Number79167602
Word MarkINZIMYA
Filing DateTuesday, March 24, 2015
Status709 - CANCELLED - SECTION 71
Status DateFriday, August 5, 2022
Registration Number4887379
Registration DateTuesday, January 19, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 3, 2015

Trademark Statements

Goods and ServicesPharmaceutical and veterinary preparations for the treatment of cancer; diagnostic preparations for medical purposes; sanitary preparations for medical purposes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, August 5, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAPEIRON BIOLOGICS AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressAT
Party NameAPEIRON BIOLOGICS AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressAT
Party NameAPEIRON BIOLOGICS AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressAT

Trademark Events

Event DateEvent Description
Saturday, November 4, 2023NEW REPRESENTATIVE AT IB RECEIVED
Saturday, June 17, 2023TOTAL INVALIDATION PROCESSED BY THE IB
Wednesday, May 24, 2023TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Wednesday, May 24, 2023INVALIDATION PROCESSED
Wednesday, April 5, 2023TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, August 5, 2022CANCELLED SECTION 71
Friday, November 26, 2021NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, January 19, 2021COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Saturday, July 9, 2016FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, April 20, 2016FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, April 20, 2016FINAL DISPOSITION PROCESSED
Tuesday, April 19, 2016FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, January 19, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, November 3, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 3, 2015PUBLISHED FOR OPPOSITION
Wednesday, October 14, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, September 25, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, September 15, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 15, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 15, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 8, 2015ASSIGNED TO LIE
Monday, August 24, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, August 1, 2015REFUSAL PROCESSED BY IB
Friday, July 10, 2015NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, July 10, 2015REFUSAL PROCESSED BY MPU
Thursday, July 9, 2015NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, July 8, 2015NON-FINAL ACTION WRITTEN
Tuesday, June 30, 2015APPLICATION FILING RECEIPT MAILED
Saturday, June 27, 2015ASSIGNED TO EXAMINER
Friday, June 26, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 25, 2015SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

inzimya preparations medical purposes diagnostic sanitary cancer veterinary treatment pharmaceutical